PPT-Migraine Other pharmacological treatments

A source of some controversy certain opioids are recommended in some guidelines eg by the American Headache Society 4 but advised against in others eg by Canadian Headache Society and European Headache Federation. The expanding border is often described as “shimmering” or associated with “zig-zag” lines, “heat waves,” or “sparklers.” While most frequently followed by a Know the Difference to Loosen the Vise. Program Goals. What Is a Migraine?. How Does Migraine Affect Quality of Life?. Episodic vs Chronic Migraine. Profiles of Episodic vs Chronic Migraine. Abbreviations. My head doth ake . O Sappho! Take . Thy fillit, . And bind the paine; . Or bring some bane . To kill it.. Robert Herrick (1591–1674). The Head-ake. History. Migraines described by Egyptians as early as 1200 BCE. David Watson, MD. Director, WVU Headache Center. EPIDEMIOLOGY . AND IMPACT. Resolving barriers to care requires several interventions. Migraine is . a common, often disabling disease of the nervous system. Gaston. Migraines. Chief Complaint. : “ I’ve . been having really bad headaches that won’t go away.”. HPI. : Patient . L.R. . . is a . 28 . year old Caucasian . female . that presents to the clinic with complaints . 10-12% of general population are active migraineurs (at least one attack in last year).. > 5% have at least 18 migraine days per year.. Female: Male ratio 3:1 – this ratio rises from menarche, peaks at 42, then declines.. AMG334 /Aimovig™ . Goadsby. PJ, Reuter U, . Hallström. Y, . Broessner. G, Bonner JH, Zhang F, . Sapra. S, Picard H, . Mikol. DD, Lenz RA. N . Engl. J Med 2017; 377:2123-2132 November 30, 2017. By Tammy Butler, Pharm.D.. Disclosure . Presenter is not affiliated with any manufacturers of the mentioned products or devices in this presentation. . Objectives. Learning Objectives (Pharmacist):. Learning Objectives (Pharmacy Technician):. Elizabeth Ekpo Cutter MDMigraine as defined by the International Classification of Headache Disorders third edition ICHD-3 should include the following1At least 5 or more attacks in lifetime2Headache CLINICAL CONDITIONS . IN WHICH 5-HT . PLAYS A ROLE . (. carcinoid syndrome and pulmonary . hypertension. .). The . most common types of headaches . are: . migraine, tension-type, . and cluster . headaches.. A person may experience migraine both with and without aura, and the aura experience varies between and within individuals. 1. Compared with migraine without aura, migraine with aura appears to have:. Migraine is a chronic neurological disease with episodic attacks of head pain. 1. If caused by another medical condition, the headache is said to be a secondary headache. 2. Migraine is characterised, including by . AMPP=American Migraine Prevalence and Prevention; COPD=chronic obstructive pulmonary disease; MHD=monthly headache day. 1. Buse et al. Headache 2020;60(10):2340–2356. Prevalence of various comorbidities among people with migraine based on headache frequency . *p<0.05, **p<0.01, ***p≤0.001; values shown in black are odds ratios comparing chronic migraine and episodic migraine. AMPP=American Migraine Prevalence and Prevention; COPD=chronic obstructive pulmonary disease; PHQ-9=Patient Health Questionnaire – 9 items.